Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

NCT06429735 is registered in ClinicalTrials.gov with Neuralink Corp as lead sponsor.

NCT NCT06429735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06429735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
Lead sponsor
Neuralink Corp
Phase
Not applicable
Overall status
Recruiting
Start date
January 9, 2024
Completion date
January 31, 2031
Enrollment
15 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis, cervical spinal cord injury, quadriplegia, quadriplegia/tetraplegia, tetraplegia/tetraparesis, tetraplegic; paralysis